(1)
Development and Characterization of a Combination Tablet Dosage Form Containing Sofosbuvir and Ribavirin Using Design of Experiments (DoE) Approach. Dhaka Univ. J. Pharm. Sci 2021, 20 (1), 121-133. https://doi.org/10.3329/dujps.v20i1.54040.